Behavioral Drug Approvals in 2020
The FDA’s Center for Drug Evaluation and Research approved 53 new drugs in 2020 alone, including several novel treatments for schizophrenia and other behavioral health conditions. What do providers need to know about these new medications?
Genoa Healthcare’s Chief Procurement Officer Stephanie Kornechuk, PharmD, recently hosted a webinar in which she addressed new behavioral drugs and their unique attributes. To learn more, watch the webinar, which:
- Reviews 2020 behavioral drug approvals
- Looks ahead at coming drug trends
- Covers recent policy changes impacting treatment of opioid use disorder
- Touches on recent COVID-19 vaccine developments
To learn more about how Genoa can help you and those you serve, contact us today.